Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Westerink

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Journal of the American Heart Association|December 22, 2021
Impact of a Patient's Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision MakingTamar I de Vries, Manon C Stam-Slob, Ron J G Peters, et al.
Frontiers in Surgery|February 2, 2023
Functional outcome of arterial thoracic outlet syndrome treatmentRobert J C M F de Kleijn, Ludo Schropp, Jan Westerink, et al.
Cardiovascular Diabetology|November 10, 2021
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetesShahnam Sharif, Y Van der Graaf, M J Cramer, et al.
Diabetes Care|May 23, 2018
Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 DiabetesNordin M J Hanssen, Jan Westerink, Jean L J M Scheijen, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 11, 2018
Editor's Choice - Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting: A Systematic Review and Meta-analysisAnne E Huibers, Jan Westerink, Evelien E de Vries, et al.
Diabetes Care|August 27, 2015
Body weight, metabolic dysfunction, and risk of type 2 diabetes in patients at high risk for cardiovascular events or with manifest cardiovascular disease: a cohort studyBas T Franssens, Yolanda van der Graaf, L Jaap Kappelle, et al.
Atherosclerosis|December 25, 2012
High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA studyJan Westerink, John E Deanfield, Ben P Imholz, et al.
Heart (British Cardiac Society)|January 5, 2024
Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Martin Teraa, et al.
Diabetes, Obesity & Metabolism|May 8, 2019
Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohortShahnam Sharif, Rolf H H Groenwold, Yolanda van der Graaf, et al.
Diabetes, Obesity & Metabolism|October 6, 2022
Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE studyHelena Bleken Østergaard, Valerie Humphreys, Ellen Margo Hengeveld, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Journal of the American Heart Association|December 22, 2021
Impact of a Patient's Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision MakingTamar I de Vries, Manon C Stam-Slob, Ron J G Peters, et al.
Frontiers in Surgery|February 2, 2023
Functional outcome of arterial thoracic outlet syndrome treatmentRobert J C M F de Kleijn, Ludo Schropp, Jan Westerink, et al.
Cardiovascular Diabetology|November 10, 2021
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetesShahnam Sharif, Y Van der Graaf, M J Cramer, et al.
Diabetes Care|May 23, 2018
Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 DiabetesNordin M J Hanssen, Jan Westerink, Jean L J M Scheijen, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 11, 2018
Editor's Choice - Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting: A Systematic Review and Meta-analysisAnne E Huibers, Jan Westerink, Evelien E de Vries, et al.
Diabetes Care|August 27, 2015
Body weight, metabolic dysfunction, and risk of type 2 diabetes in patients at high risk for cardiovascular events or with manifest cardiovascular disease: a cohort studyBas T Franssens, Yolanda van der Graaf, L Jaap Kappelle, et al.
Atherosclerosis|December 25, 2012
High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA studyJan Westerink, John E Deanfield, Ben P Imholz, et al.
Heart (British Cardiac Society)|January 5, 2024
Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Martin Teraa, et al.
Diabetes, Obesity & Metabolism|May 8, 2019
Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohortShahnam Sharif, Rolf H H Groenwold, Yolanda van der Graaf, et al.
Diabetes, Obesity & Metabolism|October 6, 2022
Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE studyHelena Bleken Østergaard, Valerie Humphreys, Ellen Margo Hengeveld, et al.
Pageof 12